US2751392A - Tertiary amine derivatives of nu-and omicron-saccharin - Google Patents
Tertiary amine derivatives of nu-and omicron-saccharin Download PDFInfo
- Publication number
- US2751392A US2751392A US393964A US39396453A US2751392A US 2751392 A US2751392 A US 2751392A US 393964 A US393964 A US 393964A US 39396453 A US39396453 A US 39396453A US 2751392 A US2751392 A US 2751392A
- Authority
- US
- United States
- Prior art keywords
- saccharin
- compounds
- pseudo
- omicron
- novel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229940081974 saccharin Drugs 0.000 title description 11
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 title description 11
- 150000003512 tertiary amines Chemical class 0.000 title description 2
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical class C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 239000002798 polar solvent Substances 0.000 claims description 2
- 150000001350 alkyl halides Chemical class 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 description 22
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 20
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 16
- 150000003839 salts Chemical class 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 12
- 238000002844 melting Methods 0.000 description 9
- 230000008018 melting Effects 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 7
- 239000002585 base Substances 0.000 description 7
- -1 Dimethylaminoethyl Chemical group 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- 230000002194 synthesizing effect Effects 0.000 description 5
- VBEJRJPHNPIURV-UHFFFAOYSA-N 3-chloro-1,2-benzothiazole 1,1-dioxide Chemical compound C1=CC=C2C(Cl)=NS(=O)(=O)C2=C1 VBEJRJPHNPIURV-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 4
- 239000012458 free base Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- SSOLNOMRVKKSON-UHFFFAOYSA-N proguanil Chemical compound CC(C)\N=C(/N)N=C(N)NC1=CC=C(Cl)C=C1 SSOLNOMRVKKSON-UHFFFAOYSA-N 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 239000000730 antalgic agent Substances 0.000 description 2
- 230000002917 arthritic effect Effects 0.000 description 2
- 230000000973 chemotherapeutic effect Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 125000005343 heterocyclic alkyl group Chemical group 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 2
- 150000003949 imides Chemical class 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 235000019204 saccharin Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229940105325 3-dimethylaminopropylamine Drugs 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- 101150030352 Arsi gene Proteins 0.000 description 1
- 241000543381 Cliftonia monophylla Species 0.000 description 1
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 1
- 150000001414 amino alcohols Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 125000004103 aminoalkyl group Chemical group 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000004985 dialkyl amino alkyl group Chemical group 0.000 description 1
- 125000004663 dialkyl amino group Chemical group 0.000 description 1
- IUNMPGNGSSIWFP-UHFFFAOYSA-N dimethylaminopropylamine Chemical compound CN(C)CCCN IUNMPGNGSSIWFP-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000011491 glass wool Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 description 1
- 229940006461 iodide ion Drugs 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
- C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
Definitions
- compositions of matter particularly to chemotherapeutic organic compounds and methods of their preparation and more particularly to R compounds useful as analgesic and antihistaminic agents may represent a heterocyclic ring system such as pyr.
- the lnventlon Involves the discovery and Formula 1(a) Shows h y of compound d ri bl c n e p the dlsdosufe of novel types of eerhpouhds from linkage of the side chain to the 'saccharin nucleus hereinafter referred to as the N- and O- saccharm derivathrough an ether l k; Formula v1 1 h type b i bl tives, the parent bases, slmple salts, and quaternary salts 20 by substituting on the imide nitrogen; and F l 1( th the type obtainable by linkage through an amino group
- These novelcompounds possess umque solublhty charto the carbon adjacent to the i id ni aot l w, which 13 unusual 111 the Whole elass of se The first class of saccharin derivatives, i.
- Convenientl j l Rmperty makes them sultahle, i eh the derivative is isolated from the reaction mixture as the by mleehoh routes as Well as ofahy form of hydrochloride, from which the various bases and other y p tablets, E P fl absol'Ptloh of these salts may be obtained by suitable means such as ion expounds when used medlcmally 1S obtamed' change or ion interaction.
- This class of compounds read- These novel types of compounds have been found Slut ily forms quaternary salts by treatment of the bases with able for the symptomatic relief of certain types of neuraldesired alkyl ha1ides gia, rheumatoid and arthritic disjorders and in h h
- the second class of 'saccharin derivatives (Formula a e h hound to PosseSS Varying degrees of ahhhlsta' 1-(b)) are obtained by reacting equimolecular quantities mlmc h of sodium saccharide with the desired dialkylaminoalkyl F E Y 1t 15 a besle obleet of t Preseht mvehhoh (or heterocyclic alkyl) halide in a polar solvent such as to provlde novel organic compounds and me for the dimethylformamide.
- the free bases are obtained directly Preparatlon e by this reaction and may then be converted to the desired h obleet 18 to P K hovel eehlpouhds e 4 simple salts or quaternary salts by neutralization or treatacterlzed by chemotherapeutic or medicinal propert es meat with appropriate ,1 halides P q l y by ahalgesleehd ahhhlsmmlmc Physio
- the third class of saccharin derivatives (Formula 10816211 aetlvlty m the mammaheh speeles' 1(0)) are obtained by reaction of equimolecular quan- Another Specific object to P i novel compounds tities of pseudo-saccharin chloride with the desired dialkylnamely, and saeehahh dehvahves, the Parent bases aminoalkyl (or heterocyclic alkyl) amine in a suitable imple salts and quaternary salts
- the hydrochloride On treatment of the free base dissolved in methanol or ethanol with a saturated solution of HCl in ethanol and precipitation with ether, the hydrochloride was obtained. It was characterized by a melting point 217- 218 C. and a chloride ion content of 11.25%. The theoretically predicted chloride ion content was 11.12%.
- the methiodide The free base, dissolved in anhydrous acetone and treated with an excess of methyl iodide, upon standing for several hours yielded the methiodide, which had a melting point of 199-200" C.
- the iodide content found was 30.04% which compares very closely to the theoretical iodide content, which is 29.91%.
- N-morpholinoethyl saccharin In the manner described under Example I, the N-morpholinoethyl derivative was obtained in 80% yield of the free base when the reaction was run in 0.25 molar quantity. This substance had a boiling point of 180- 184 C. at 0.1 mm. pressure and a melting point of 103-l04 C.
- the methiodide Conversion to the methiodide was effected in anhydrous methanol by means of an excess quantity of methyl iodide.
- This quaternary salt had a melting point of 259-260 C. and iodide ion was found to be present in the amount of 29.36% as compared to 28.96% calculated theoretically for this salt.
- the N-saccharins are similarly etfective administered orally, twice daily in 60 milligram dosages.
- N- and O- saccharin derivatives taken from the group consisting of where x represents a number from 2 to 6, and
- dialkylamino having 1 to 6 carbon atoms in each alkyl chain and the heterocyclic ring systems of pyrrolidine, morpholine and piperidi'ne.
- the saccharin derivative having the formula namely, N diethylaminoethyl saccharin.
- the hydrochloride salt of the saccharin derivative having the formula Ci CHa namely, dimethylaminoethyl pseudo-saccharin ether.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
United States Patent Ice Patented $2, 1 55 2,751,392 TERTIARY AMINE DERIVATIVES or N- AND O-SACCHARIN R Charles H. Grogan, Falls Church, Va., and Leonard M. N Rice, Baltimore, Md., assignors to Geschickter Fund for 50/ Medical Research, Inc., New York, N. Y., a c'orporation of New York No Drawing. Application November 23, 1953, In these formulae, x represents a number from 2 to 6 Serial 4 and -R represents an alkyl group having from 1 to 6 carbon 7 Claims. (Cl. 260-301) atoms, or the grouping This invention relates to compositions of matter, particularly to chemotherapeutic organic compounds and methods of their preparation and more particularly to R compounds useful as analgesic and antihistaminic agents may represent a heterocyclic ring system such as pyr.
in m u p rolidine, morpholine and piperidine.
Specifically, the lnventlon Involves the discovery and Formula 1(a) Shows h y of compound d ri bl c n e p the dlsdosufe of novel types of eerhpouhds from linkage of the side chain to the 'saccharin nucleus hereinafter referred to as the N- and O- saccharm derivathrough an ether l k; Formula v1 1 h type b i bl tives, the parent bases, slmple salts, and quaternary salts 20 by substituting on the imide nitrogen; and F l 1( th the type obtainable by linkage through an amino group These novelcompounds possess umque solublhty charto the carbon adjacent to the i id ni aot l w, which 13 unusual 111 the Whole elass of se The first class of saccharin derivatives, i. e., those repcharln Compounds except for the sodlhm salt- The resented by Formula 1(a), are obtained by reacting equihi e lic arsi h ft z l fli l tgd s i f so l iib le ih ig gg lecular amounts of pseudo saccharin chloride with the s desired amino alcohol in suitable media. Convenientl j l Rmperty makes them sultahle, i eh the derivative is isolated from the reaction mixture as the by mleehoh routes as Well as ofahy form of hydrochloride, from which the various bases and other y p tablets, E P fl absol'Ptloh of these salts may be obtained by suitable means such as ion expounds when used medlcmally 1S obtamed' change or ion interaction. This class of compounds read- These novel types of compounds have been found Slut ily forms quaternary salts by treatment of the bases with able for the symptomatic relief of certain types of neuraldesired alkyl ha1ides gia, rheumatoid and arthritic disjorders and in h h The second class of 'saccharin derivatives (Formula a e h hound to PosseSS Varying degrees of ahhhlsta' 1-(b)) are obtained by reacting equimolecular quantities mlmc h of sodium saccharide with the desired dialkylaminoalkyl F E Y 1t 15 a besle obleet of t Preseht mvehhoh (or heterocyclic alkyl) halide in a polar solvent such as to provlde novel organic compounds and me for the dimethylformamide. The free bases are obtained directly Preparatlon e by this reaction and may then be converted to the desired h obleet 18 to P K hovel eehlpouhds e 4 simple salts or quaternary salts by neutralization or treatacterlzed by chemotherapeutic or medicinal propert es meat with appropriate ,1 halides P q l y by ahalgesleehd ahhhlsmmlmc Physio The third class of saccharin derivatives (Formula 10816211 aetlvlty m the mammaheh speeles' 1(0)) are obtained by reaction of equimolecular quan- Another Specific object to P i novel compounds tities of pseudo-saccharin chloride with the desired dialkylnamely, and saeehahh dehvahves, the Parent bases aminoalkyl (or heterocyclic alkyl) amine in a suitable imple salts and quaternary salts thereof. medium such as acetone or benzene. These compounds equally Important f l of the Invention to are obtained from the reaction mixture as the hydrochlovlde methods of syntheslzlhg the novel compounds ride salts which may be converted into the base, other ferred to m the foregomg p g simple salts, or may be quaternized as desired.
These and other Submemate ohlects and the manner Following are particularized examples of the general Whleh they are aeeomphshed W111 become apparent synthesizing processes described above--and specific resultthose conversant with the art from the following descnping members the novel general classes of compounds tion of the general types of novel compounds discovered discovered and certain specific examples of particular members there- EXAMPLE I of as well as general and specific methods of their synthesis. N-diethylaminoethyl saccharz'n Generally Stated the novel compounds embraced by The synthesizing reaction for the preparation of this :3: g gfi gg gg gg gigzi i i gig z i i gg 2: compound is illustrated by the following equation: carbon adjacent to the imide nitrogen, coupled through an oxygen ether linkage or an amino nitrogen linkage, o and forming suitable simple or quaternary salts of the bases thus obtained. so, cm
The types of compounds discovered are specifically illustrated by Formulae 1(a), 1(b) and 1(0) which follow: I U2H5 /R N-CiH4'-N 0-(CHa),N 0 can,
R R 0 In carrying out the synthesis indicated by this equation, 51 grams (0.25 mole) of sodium saccharide was dissolved R in m1. of diinethylfor'man ide and the solution rem) 1(0) fluxed for 3 hours with 33 grams of diethylaminoe'thyl chloride. Separation of sodium chloride was evident after a few minutes and the reaction was essentially complete in 3 hours. The reaction mixture was then filtered to remove the salt formed and the dimethylformamide removed from the filtrate under reduced pressure. Finally, the resulting oil was filtered through glass wool and distilled in vacuo and a yield of 55 grams of the free base was obtained. The substance solidified in the receiver and had a melting point of 61-63 C. and boiled at 144- 150 C. at a pressure of 0.06 mm.
The hydrochloride On treatment of the free base dissolved in methanol or ethanol with a saturated solution of HCl in ethanol and precipitation with ether, the hydrochloride was obtained. It was characterized by a melting point 217- 218 C. and a chloride ion content of 11.25%. The theoretically predicted chloride ion content was 11.12%.
The methiodide The free base, dissolved in anhydrous acetone and treated with an excess of methyl iodide, upon standing for several hours yielded the methiodide, which had a melting point of 199-200" C. The iodide content found was 30.04% which compares very closely to the theoretical iodide content, which is 29.91%.
EXAMPLE II N-morpholinoethyl saccharin In the manner described under Example I, the N-morpholinoethyl derivative was obtained in 80% yield of the free base when the reaction was run in 0.25 molar quantity. This substance had a boiling point of 180- 184 C. at 0.1 mm. pressure and a melting point of 103-l04 C.
The hydrochloride Conversion to the hydrochloride was eflected in the same manner as outlined in Example I and yielded the salt with a melting point of 236 C. The analysis for chloride ion content gave a value of 10.76% which checks closely with the theoretical value of 10.65%.
The methiodide Conversion to the methiodide was effected in anhydrous methanol by means of an excess quantity of methyl iodide. This quaternary salt had a melting point of 259-260 C. and iodide ion was found to be present in the amount of 29.36% as compared to 28.96% calculated theoretically for this salt.
EXAMPLE III Dimethylaminoethyl pseudo-saccharin ether The synthesizing reaction for the preparation of this compound is illustrated by the following equation:
N so/ In carrying out the synthesis indicated by this equation, 40 grams (0.2 mole) of pseudo-saccharin chloride was dissolved in 250 ml. of anhydrous acetone with gentle heating. After solution had been effected, 18 grams (0.2 mole) of dimethylaminoethyl alcohol dissolved in 50 ml. of acetone was slowly added. The reaction was instantaneous and exothermic. The mixture, after re-v fluxing gently for /2 hour, was cooled and filtered and Melting Percent chloride ion Example Compound Point,
Actual Theoretical IV Piperidinoethyl pseudo- -151 10. 33 10. 72
saceharln ether (hydro chloride) V Pyrrolidinoethyl 151-152 11.46 11.19
pseudo-saccharin ether (hydrochloride). VI Beta-di-n-butylamino- 135437 9. 30 9. 16
propyl pseudo-saccharin ether (hydrochloride).
EXAMPLE VII I C-dz'methylaminopropyl amino pseudo-saccharin The synthesizing reaction for the preparation of this compound is illustrated by the following equation:
In carrying out this synthesis, 40 grams (0.2 mole) of pseudo-saccharin chloride was dissolved with gentle heating in 250 m1. of anhydrous acetone. After solution was complete, 20.4 grams (0.2 mole) of 3-dimethylaminopropyl amine dissolved in 50 ml. of acetone was added rapidly but cautiously. An exothermic reaction ensued and the product precipitated out in the form of colorless crystals. The mixture was refluxed gently for an additional /2 hour, cooled, filtered and washed with anhydrous acetone and then ether and dried. The resulting compound had a melting point of 206-207 C. and analysis thereof showed a chloride ion content of 11.67% which is exactly the value arrived at by theoretical calculations.
EXAMPLE VIII C-diethylaminoethylamino pseudo-saccharin This compound, prepared by means of a reaction analogous to that described in Example II using the appropriate amine, on standing 4 days yielded a crystalline product which on filtering, washing with acetone and ether, and drying, had a melting point of 166 C. and a chloride ion content (11.18%) extremely close to the theoretical value (11.16%).
EXAMPLE IX Y C-rrrorpholinoethylamino pseudo-saccharin this discovery in the symptomatic treatment of certain diseases has already been mentioned hereinabove. The O-saccharins have been found to be of particular value as analgesics in the treatment of neuralgia, arthritic and various related rheumatoid disorders. To this end a recommended effective dosage is 250 to 330 milligrams given orally or 50 milligrams by injection, in either case once a day.
The N-saccharins are similarly etfective administered orally, twice daily in 60 milligram dosages.
From the foregoing description of novel classes of compounds, particular exemplary members of the classes and general and specific methods of synthesizing same, it will be understood that on the basis of the discovery and knowledge disclosed herein other specific compounds have been and can be made and variations in the methods of synthesis resorted to. Therefore specific compounds and methods disclosed herein are to be considered in all respects as illustrative and not restrictive, the scope of the discovery being indicated by the appended claims rather than by the foregoing description, and all specific compounds and variations in method which come within the meaning and range of equivalency of the claims are therefore intended to be embraced therein.
What is claimed and desired to be secured by the United States Letters Patent is:
1. As novel compositions of matter, the N- and O- saccharin derivatives taken from the group consisting of where x represents a number from 2 to 6, and
is taken from the group consisting of the dialkylamino having 1 to 6 carbon atoms in each alkyl chain and the heterocyclic ring systems of pyrrolidine, morpholine and piperidi'ne.
2. As novel compositions of matter the saccharin derivatives having the formula where, in said formula, x is 2 and R is methyl.
3. As novel compositions of matter, the saccharin derivative having the formula namely, N diethylaminoethyl saccharin.
4. As novel compositions of matter, the hydrochloride salt of the saccharin derivative having the formula Ci CHa namely, dimethylaminoethyl pseudo-saccharin ether.
5. As novel compositions of matter, the sacchari'n derivative having the formula References Cited in the file of this patent UNITED STATES PATENTS 2,538,645 Hamilton Jan. 16, 1951
Claims (2)
1. AS NOVEL COMPOSITIONS OF MATTER, THE N- AND OSACCHARIN DERIVATIVES TAKEN FROM THE GROUP CONSISTING OF
6. THE METHOD OF PREPARING SACCHARIN DERIVATIVES COMPRISED IN REACTING SODIUM SACCHARIDE WITH AN ALKYL HALIDE SELECTED FROM THE GROUP CONSISTING OF DIALKYLAMINOALKYL AND HETEROCYCLIC ALKYL HALIDES IN A POLAR SOLVENT.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US393964A US2751392A (en) | 1953-11-23 | 1953-11-23 | Tertiary amine derivatives of nu-and omicron-saccharin |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US393964A US2751392A (en) | 1953-11-23 | 1953-11-23 | Tertiary amine derivatives of nu-and omicron-saccharin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US2751392A true US2751392A (en) | 1956-06-19 |
Family
ID=23556970
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US393964A Expired - Lifetime US2751392A (en) | 1953-11-23 | 1953-11-23 | Tertiary amine derivatives of nu-and omicron-saccharin |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US2751392A (en) |
Cited By (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2854456A (en) * | 1955-07-25 | 1958-09-30 | Ciba Pharm Prod Inc | New ganglionic blocking agents |
| DE1147947B (en) * | 1961-07-25 | 1963-05-02 | Knoll Ag | Process for the preparation of new 1,2-benzisothiazolones |
| DE1165033B (en) * | 1957-10-09 | 1964-03-12 | Merck iλ Co., Inc., Rahway, N. J. (V. St. A.) | Process for the preparation of sulfamyl saccharin compounds. |
| DE1174783B (en) * | 1962-03-01 | 1964-07-30 | Knoll Ag | Process for the preparation of new basic substituted 1,2-benzisothiazoles |
| US3164602A (en) * | 1962-10-05 | 1965-01-05 | American Home Prod | Novel benzisothiazoline dioxides |
| US4104387A (en) * | 1977-05-23 | 1978-08-01 | E. R. Squibb & Sons, Inc. | 3-(Arylcycloiminoalkyl)benzisothiazole 1,1-dioxides |
| US4104388A (en) * | 1977-05-23 | 1978-08-01 | E. R. Squibb & Sons, Inc. | 3-Substituted benzisothiazole, 1,1-dioxides |
| US4108860A (en) * | 1978-02-03 | 1978-08-22 | E. R. Squibb & Sons, Inc. | Triazolobenzisothiazole-1,1-dioxides |
| US4110449A (en) * | 1977-05-23 | 1978-08-29 | E. R. Squibb & Sons, Inc. | 2-substituted benzisothiazol-3-ones |
| US4147698A (en) * | 1978-07-13 | 1979-04-03 | E. R. Squibb & Sons, Inc. | 3-(Heterocyclicalkylamino)benzisothiazole-1,1-dioxides |
| US4148798A (en) * | 1978-02-03 | 1979-04-10 | E. R. Squibb & Sons, Inc. | [(1,1-dioxo-1,2-benzisothiazol-3-yl)amino]alkanoic acids and esters thereof |
| FR2416226A1 (en) * | 1978-02-03 | 1979-08-31 | Squibb & Sons Inc | BENZISOTHIAZOLE-1,1-DIOXIDES AND THEIR THERAPEUTIC USE |
| US4166910A (en) * | 1978-07-13 | 1979-09-04 | E. R. Squibb & Sons, Inc. | 3-(Nitrogen containing heterocyclic)amino) benzisothiazole-1,1-dioxide |
| US4174442A (en) * | 1978-02-03 | 1979-11-13 | E. R. Squibb & Sons, Inc. | Substituted hydrazino derivatives of benzisothiazole-1,1-dioxides |
| US4178451A (en) * | 1978-07-13 | 1979-12-11 | E. R. Squibb & Sons, Inc. | 3-(Substituted hydrazino)benzisothiazole-1,1-dioxides |
| US4208518A (en) * | 1978-02-03 | 1980-06-17 | E. R. Squibb & Sons, Inc. | Substituted hydrazino derivatives of benzisothiazole-1,1-dioxides |
| EP0086748A1 (en) * | 1982-02-12 | 1983-08-24 | Ciba-Geigy Ag | 3-Amidine-benzisothiazole-1,1 dioxides, process for their preparation and their use as pesticides |
| EP0033984B1 (en) * | 1980-01-23 | 1984-06-06 | Duphar International Research B.V | New sulphonyl compounds, method of preparing the new compounds, as well as aphicidal compositions on the basis of the new compounds |
| EP0236930A1 (en) * | 1986-03-05 | 1987-09-16 | Merrell Dow Pharmaceuticals Inc. | Aromatic 2-aminoalkyl-1,2-benzoisothiazol-3(2H)one-1,1-dioxide derivatives |
| US4855311A (en) * | 1987-04-24 | 1989-08-08 | Agro-Kanesho Co., Ltd. | Benzoisothiazole oximes which are plant protection agents for control of fungi and bacteria |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2538645A (en) * | 1948-10-18 | 1951-01-16 | William F Hamilton | Vasoconstrictor compounds of saccharin and pharmaceutical compositions produced therefrom |
-
1953
- 1953-11-23 US US393964A patent/US2751392A/en not_active Expired - Lifetime
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2538645A (en) * | 1948-10-18 | 1951-01-16 | William F Hamilton | Vasoconstrictor compounds of saccharin and pharmaceutical compositions produced therefrom |
Cited By (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2854456A (en) * | 1955-07-25 | 1958-09-30 | Ciba Pharm Prod Inc | New ganglionic blocking agents |
| DE1165033B (en) * | 1957-10-09 | 1964-03-12 | Merck iλ Co., Inc., Rahway, N. J. (V. St. A.) | Process for the preparation of sulfamyl saccharin compounds. |
| DE1147947B (en) * | 1961-07-25 | 1963-05-02 | Knoll Ag | Process for the preparation of new 1,2-benzisothiazolones |
| US3227715A (en) * | 1961-07-25 | 1966-01-04 | Knoll Ag | Benzisothiazolones |
| DE1174783B (en) * | 1962-03-01 | 1964-07-30 | Knoll Ag | Process for the preparation of new basic substituted 1,2-benzisothiazoles |
| US3164602A (en) * | 1962-10-05 | 1965-01-05 | American Home Prod | Novel benzisothiazoline dioxides |
| US4104387A (en) * | 1977-05-23 | 1978-08-01 | E. R. Squibb & Sons, Inc. | 3-(Arylcycloiminoalkyl)benzisothiazole 1,1-dioxides |
| US4104388A (en) * | 1977-05-23 | 1978-08-01 | E. R. Squibb & Sons, Inc. | 3-Substituted benzisothiazole, 1,1-dioxides |
| US4110449A (en) * | 1977-05-23 | 1978-08-29 | E. R. Squibb & Sons, Inc. | 2-substituted benzisothiazol-3-ones |
| US4108860A (en) * | 1978-02-03 | 1978-08-22 | E. R. Squibb & Sons, Inc. | Triazolobenzisothiazole-1,1-dioxides |
| US4174442A (en) * | 1978-02-03 | 1979-11-13 | E. R. Squibb & Sons, Inc. | Substituted hydrazino derivatives of benzisothiazole-1,1-dioxides |
| US4148798A (en) * | 1978-02-03 | 1979-04-10 | E. R. Squibb & Sons, Inc. | [(1,1-dioxo-1,2-benzisothiazol-3-yl)amino]alkanoic acids and esters thereof |
| FR2416226A1 (en) * | 1978-02-03 | 1979-08-31 | Squibb & Sons Inc | BENZISOTHIAZOLE-1,1-DIOXIDES AND THEIR THERAPEUTIC USE |
| US4208518A (en) * | 1978-02-03 | 1980-06-17 | E. R. Squibb & Sons, Inc. | Substituted hydrazino derivatives of benzisothiazole-1,1-dioxides |
| US4147698A (en) * | 1978-07-13 | 1979-04-03 | E. R. Squibb & Sons, Inc. | 3-(Heterocyclicalkylamino)benzisothiazole-1,1-dioxides |
| US4178451A (en) * | 1978-07-13 | 1979-12-11 | E. R. Squibb & Sons, Inc. | 3-(Substituted hydrazino)benzisothiazole-1,1-dioxides |
| US4166910A (en) * | 1978-07-13 | 1979-09-04 | E. R. Squibb & Sons, Inc. | 3-(Nitrogen containing heterocyclic)amino) benzisothiazole-1,1-dioxide |
| EP0033984B1 (en) * | 1980-01-23 | 1984-06-06 | Duphar International Research B.V | New sulphonyl compounds, method of preparing the new compounds, as well as aphicidal compositions on the basis of the new compounds |
| EP0086748A1 (en) * | 1982-02-12 | 1983-08-24 | Ciba-Geigy Ag | 3-Amidine-benzisothiazole-1,1 dioxides, process for their preparation and their use as pesticides |
| US4492705A (en) * | 1982-02-12 | 1985-01-08 | Ciba-Geigy Corporation | 3-Amidino-benzisothiazole-1,1-dioxides and their use for controlling pests |
| EP0236930A1 (en) * | 1986-03-05 | 1987-09-16 | Merrell Dow Pharmaceuticals Inc. | Aromatic 2-aminoalkyl-1,2-benzoisothiazol-3(2H)one-1,1-dioxide derivatives |
| US4855311A (en) * | 1987-04-24 | 1989-08-08 | Agro-Kanesho Co., Ltd. | Benzoisothiazole oximes which are plant protection agents for control of fungi and bacteria |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US2751392A (en) | Tertiary amine derivatives of nu-and omicron-saccharin | |
| US2951082A (en) | Substituted thiaxanthenes | |
| JPS6056143B2 (en) | Amidine derivatives and their production method | |
| CA1257271A (en) | 6-vinyl-furo-(3,4-c)-pyridine derivatives | |
| JPH054983A (en) | Isoquinolinone derivative, method for producing the same, and 5-HT3 receptor antagonist containing the derivative as an active ingredient | |
| JPS5919549B2 (en) | Heterocyclic compounds | |
| US3267107A (en) | 3-(4'-5'-methylenedioxy-phenyl)-7, 8-dimethoxy-1, 2, 3, 4,-tetrahydroisoquinolines | |
| US3907826A (en) | Novel benzo(b)thiophene derivatives and processes for their preparation | |
| US3668208A (en) | Hexahydro imidazoquinolines | |
| Shapiro et al. | N-substituted-3-oxypyridyl betaines | |
| JPS61109767A (en) | Oxindol anti-inflammatory agent | |
| US3198798A (en) | Phthalimido- and isoindolinyl-alkylpiperazines and their preparation | |
| US3882134A (en) | 1-Substituted-3,5-dipyridyl-1,2,4-triazoles | |
| US3396165A (en) | 9-aminomethyl-3, 8-diloweralkyl-10-hydroxy-5-oxo-1, 2, 3, 4-tetrahydrobenzopyrano [3,4-c] pyridines | |
| US3948908A (en) | Pyridopyridazine derivatives | |
| US3697505A (en) | Aromatic substituted amidines | |
| US3325489A (en) | Substituted 3-hydroxydibenzopyrans | |
| US3325490A (en) | Substituted 1-hydroxydibenzopyrans | |
| US3433836A (en) | Alpha-diaryl alpha,omega-alkylene glycol-dilower-alkylamines | |
| US4012394A (en) | Indole derivatives | |
| US3725424A (en) | 3,5-substituted-1,2,4-oxadiazole inner quaternary ammonium salts | |
| US2553994A (en) | Pyridine therapeutic compounds | |
| US3951970A (en) | Resorcinol amine derivatives | |
| US3184452A (en) | New aminoalkoxy compounds and process for theik manufacture | |
| US4843085A (en) | Pyridine derivatives, process for production thereof and pharmaceutical compositions useful as anti-arhytmics |